Literature DB >> 203202

Osteosarcoma of bone and its important recognizable varieties.

D C Dahlin, K K Unni.   

Abstract

Osteosarcoma of bone is a recognizable entity if the histopathologist designates tumors as such when their malignatn cells produce osteoid substance even if only in small foci. Such definition distinguishes this lesion from other sarcomas that arise in bone, especially chondrosarcoma and fibrosarcoma. There is a general tendency to consider that osteosarcomas represent a stereotyped form of disease for which new modalities of treatment can be applied and assessed. The question of whether a given osseous lesion is actually malignant and not a benign neoplasm or even a reactive non-neoplastic condition simulating a malignant tumor may be difficult for the histopathologist. Pathologists without considerable experience in the diagnosis of bone tumors find this question especially vexing. The establishment of a valid diagnosis of osteosarcoma introduces the additional problem that the 11 varieties considered in this paper may pose significant recognizable variations in the clinical capability of the disease. It is apparent that the physician must recognize the known clinicopathologic and prognostic factors of these subtypes in his assessment of the overall problem.

Entities:  

Mesh:

Year:  1977        PMID: 203202     DOI: 10.1097/00000478-197701010-00007

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  31 in total

1.  Case report 574. Periosteal osteoblastoma of rib.

Authors:  J F Gentry; J J Schechter; J M Mirra
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

2.  [New morphologic findings in malignant bone tumors].

Authors:  G Delling
Journal:  Langenbecks Arch Chir       Date:  1987

3.  Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.

Authors:  Jian Chen; Meng-xiong Sun; Ying-qi Hua; Zheng-dong Cai
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-31       Impact factor: 4.553

4.  Case report 523: Osteoblastic osteosarcoma of the navicular.

Authors:  C S Moss; C Williams; B I Ellis; A R Gaba
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

5.  Case report 540. Grade III conventional sclerosing osteosarcoma of the calcaneus.

Authors:  F López-Barea; F Contreras; S Sanchez-Herrera
Journal:  Skeletal Radiol       Date:  1989       Impact factor: 2.199

6.  Case report 446. Multicentric, metachronous, low-grade, sclerosing osteogenic sarcoma.

Authors:  E F McCarthy; V T Tolo; H D Dorfman
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

7.  Case report 425: Chondroblastic osteosarcoma: clear-cell variant of femur.

Authors:  A K Raymond; G F Murphy; D I Rosenthal
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

Review 8.  Advancing therapy for osteosarcoma.

Authors:  Jonathan Gill; Richard Gorlick
Journal:  Nat Rev Clin Oncol       Date:  2021-06-15       Impact factor: 66.675

9.  Biopsy technique in the treatment of osteosarcoma.

Authors:  J A Cara del Rosal; J Cañadell
Journal:  Int Orthop       Date:  1994       Impact factor: 3.075

10.  Isolation of osteosarcoma-associated human antibodies from a combinatorial Fab phage display library.

Authors:  Carmela Dantas-Barbosa; Fabrícia P Faria; Marcelo M Brigido; Andrea Q Maranhão
Journal:  J Biomed Biotechnol       Date:  2009-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.